WORK Medical Technology Group LTD is projected to decline to $1.72 by 2027, a -15% move from its current price of $2.02. WOK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.77 | $2.02 | $2.30 | +0.04% |
| Jul 14 | $1.68 | $2.02 | $2.43 | +0.07% |
| Jul 15 | $1.61 | $2.02 | $2.54 | +0.11% |
| Jul 16 | $1.56 | $2.02 | $2.63 | +0.15% |
| Jul 17 | $1.51 | $2.02 | $2.71 | +0.19% |
| Jul 18 | $1.47 | $2.02 | $2.79 | +0.22% |
| Jul 19 | $1.43 | $2.03 | $2.86 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.43 | $2.03 | $2.86 | +0.26% |
| Week 2 | $1.24 | $2.03 | $3.31 | +0.52% |
| Week 3 | $1.12 | $2.04 | $3.71 | +0.78% |
| Week 4 | $1.02 | $2.04 | $4.08 | +1.04% |
| Week 5 | $0.9436 | $2.05 | $4.44 | +1.31% |
| Week 6 | $0.8787 | $2.05 | $4.79 | +1.57% |
| Week 7 | $0.8231 | $2.06 | $5.14 | +1.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
WORK Medical Technology Group LTD is a healthcare company that manufactures and sells medical consumables and devices in the People’s Republic of China and internationally. Its product range includes medical face masks, arterial compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other medical devices such as KN95 masks and filtering half masks, nebulizer kits, SPO2 sensors, nasogastric tubes, PPE, hygiene and skincare products, and non-powered air-purifying particle respirators. The company also engages in research and development of biological and medical technology, and the sale of chemical products.
It serves hospitals, pharmacies, and medical institutions and exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has a strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models.
WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
The asset is WORK Medical Technology Group LTD (WOK), currently priced at $2.03 with a market capitalization of $4.91M. It ranks 5337 by market size, positioning it as a micro-cap within the Healthcare sector. The current price is accompanied by a near-term forecast that projects movement within a range and highlights varying sentiment over the coming years.
The century-long forecast begins at a near-term level around $2.03 (average) for 2026 and explores upside to a maximum of $18.00 by 2050, with several intermediate milestones.
A major floor 97.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.5% below — buyers have tended to step in here.
The nearest ceiling, 439.6% above — a clean break opens room to run.
A major ceiling 439.6% above — clearing it would confirm fresh momentum.
Key WOK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WOK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.08 | Sell | $2.13 | Sell |
| MA 10 | $2.10 | Sell | $2.09 | Sell |
| MA 20 | $1.96 | Buy | $1.87 | Buy |
| MA 50 | $1.34 | Buy | $5.62 | Sell |
| MA 100 | $1.28 | Buy | $194.06 | Sell |
| MA 200 | $193.60 | Sell | $2,145.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.69 | Neutral |
| Stoch RSI (14) | 34.33 | Neutral |
| CCI (20) | 29.82 | Neutral |
| Williams %R (14) | -66.96 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -12.21 | Sell |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 33.04 | Neutral |
| TRIX (15) | 4.21 | Buy |
| Awesome (5,34) | 0.89 | Buy |
| Ultimate (7,14,28) | 58.20 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 2.06 | Sell |
| ADX (14) | 17.28 | Neutral |
| ATR (14) | 0.28 | Info |
In the near term, the sentiment is NEUTRAL with an RSI(14) of 40. The 30-day technical picture shows a wide swing, with a range low of $0.7356 and a range high of $5.60. The SMA50 is listed at $64.34 and the SMA200 at $31,615.29, underscoring a marked discrepancy between price level and moving averages.
Support is identified at $1.93 and resistance at $11.20, while annualized volatility sits at 300%, indicating substantial price swings in the period ahead.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.93 | $2.02 | $3.00 | 0% | Neutral | |
| $1.25 | $1.72 | $2.57 | -15% | Neutral | |
| $1.20 | $1.76 | $2.80 | -13% | Neutral | |
| $1.63 | $2.51 | $4.18 | +24% | Bullish | |
| $1.65 | $2.67 | $4.64 | +32% | Bullish | |
| $1.70 | $2.88 | $5.17 | +42% | Bullish | |
| $1.48 | $2.62 | $4.85 | +29% | Bullish | |
| $1.16 | $2.13 | $4.06 | +5% | Neutral | |
| $1.34 | $2.55 | $4.99 | +26% | Bullish | |
| $1.28 | $2.54 | $5.07 | +26% | Bullish | |
| $1.46 | $3.24 | $7.12 | +60% | Bullish | |
| $3.53 | $7.83 | $18.02 | +288% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.93 | $2.02 | $2.58 | +0.00% |
| August 2026 | $1.80 | $2.18 | $2.75 | +7.90% |
| September 2026 | $1.70 | $2.09 | $2.69 | -4.13% |
| October 2026 | $1.70 | $2.12 | $2.77 | +1.25% |
| November 2026 | $1.81 | $2.27 | $3.02 | +7.33% |
| December 2026 | $1.76 | $2.23 | $3.00 | -1.88% |
Click any year to see its month-by-month WOK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The WOK price prediction for 2026 points to an average of $2.02 (low $1.93, high $3.00) — a potential gain of 0% on today's $2.02. Price action looks broadly range-bound.
In 2027, WOK is projected to trade between $1.25 and $2.57, averaging $1.72 — a potential decline of -15% from today's $2.02. That is -15% versus the projected 2026 average. A consolidation phase looks the most probable path here.
WORK Medical Technology Group LTD's 2028 outlook centres on $1.76, within a $1.20 to $2.80 range. That is up +2% on the projected 2027 average. That marks a -13% change versus current levels. Price action looks broadly range-bound.
By 2029, WOK could reach as high as $4.18, with a base case around $2.51 and support toward $1.63 — roughly +24% from $2.02. Buyers look set to stay in control over this stretch.
Expect WOK to range from $1.65 to $4.64 through 2030. The $2.67 average target implies a +32% move from current prices. That is up +7% on the projected 2029 average. Momentum favours further upside here.
The WOK price prediction for 2031 points to an average of $2.88 (low $1.70, high $5.17) — a potential gain of +42% on today's $2.02. Buyers look set to stay in control over this stretch.
In 2032, WOK is projected to trade between $1.48 and $4.85, averaging $2.62 — a potential gain of +29% from today's $2.02. That is -9% versus the projected 2031 average. Momentum favours further upside here.
WORK Medical Technology Group LTD's 2033 outlook centres on $2.13, within a $1.16 to $4.06 range. That is -19% versus the projected 2032 average. That marks a +5% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, WOK could reach as high as $4.99, with a base case around $2.55 and support toward $1.34 — roughly +26% from $2.02. Momentum favours further upside here.
Expect WOK to range from $1.28 to $5.07 through 2035. The $2.54 average target implies a +26% move from current prices. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The WOK price prediction for 2040 points to an average of $3.24 (low $1.46, high $7.12) — a potential gain of +60% on today's $2.02. Momentum favours further upside here.
In 2050, WOK is projected to trade between $3.53 and $18.02, averaging $7.83 — a potential gain of +288% from today's $2.02. That is up +142% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in WOK today (≈ 495.049505 WOK) could be worth
$3,878.24
+$2,878.24 (+288%) by 2050 · US Dollar
Based on the average projected WOK price of $7.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WOKwould be worth at today's price.
$1,000 invested in WOK on Jul 10, 2025 (≈ 0.12987 WOK) would be worth
$0.26
-$999.74 (-100.0%) today · 0.00× · US Dollar
Based on a WOK entry price of $7,700 vs. today's $2.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.21 | $914.03 | -8.6% |
| 1 month ago | $0.1 | $20,200 | +1920.0% |
| 3 months ago | $1.3 | $1,553.85 | +55.4% |
| 6 months ago | $2.1 | $961.9 | -3.8% |
| 1 year ago | $7,700 | $0.26 | -100.0% |
| All time (1.9y) ago | $36,000 | $0.06 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WOK forecast.
Our base-case forecast reaches $4.00 around 2050.
Implied market cap at $4.00: $9.67M
The multi-year forecast unfolding from 2026 through 2050 depicts a progression from neutral to bullish momentum, with meaningful upside potential. The 2026 average price is $2.03 (min $1.93, max $3.00) with 0% ROI and NEUTRAL sentiment. The path opens into a bullish arc from 2029 onward, with 2029 averaging $2.52 and 2030 averaging $2.70 (ROI 32.8%), 2031 averaging $2.89 (ROI 42.5%), and 2032 averaging $2.61 (ROI 28.7%).
By 2040, the average is projected at $3.28 with a 61.4% ROI and bullish sentiment, and by 2050 the average reaches $7.83 with a 285.6% ROI and bullish sentiment. The forecast also shows a maximum of $18.00 in 2050 and a 2030 max of $4.68. The annual path includes some years with neutral or lower returns (e.g., 2027 ROI -14.6%, 2028 ROI -12.4%, 2033 ROI 5.9%), illustrating the volatility and uncertainty inherent in long-horizon projections.
Overall, the long-term outlook suggests substantial upside potential if the bullish trajectory holds, but these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 forecast: min $1.67, avg $2.70, max $4.68, ROI 32.8%, sentiment BULLISH.
The near-term forecast is NEUTRAL with a 0% ROI in 2026, but the multi-year view shows bullish upside beginning around 2029, with ROI rising to 32.8% in 2030 and up to 285.6% by 2050. Some years show negative or modest returns (e.g., 2027 ROI -14.6%, 2028 ROI -12.4%), so results are uncertain and not guaranteed.
Yes, the forecast allows a maximum of $18.00 in 2050, with an average of $7.83. This implies potential upside beyond $10 in the 2050 horizon, but it is not guaranteed.
Current price is $2.03 and market cap is $4.91M.
Near-term sentiment is NEUTRAL with RSI(14) at 40. The 30-day range spans from $0.7356 to $5.60, with support at $1.93 and resistance at $11.20; the SMA50 is $64.34 and the SMA200 is $31,615.29, with annualized volatility at 300%.
WORK Medical Technology Group LTD Community Discussion
0Share your WORK Medical Technology Group LTD price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.